A Study Comparing 0.5% Levobupivacaine and 0.75% Ropivacaine for Thoracic Epidural Anaesthesia in Abdominal Surgeries
International Journal of Pharmaceutical Quality Assurance · 30.06.2026 · 17 (06)
DOI: 10.25258/ijpqa.17.6.17 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharmaceutical Quality Assurance, online erschienen am 30.06.2026. Verfasst von Chandaka Aditya Thrilochan und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Thoracic epidural anaesthesia (TEA) is widely used for abdominal surgeries as it provides effective segmental anaesthesia, reduces systemic opioid requirement, and improves perioperative analgesia. Levobupivacaine and ropivacaine are long-acting amide local anaesthetics with favourable safety profiles.
Aim
To compare the anaesthetic efficacy, duration of blockade, haemodynamic stability, conversion to general anaesthesia, and early postoperative analgesia between 0.5% levobupivacaine and 0.75% ropivacaine administered through the thoracic epidural route.
Methods
This comparative clinical study included 60 patients undergoing abdominal surgeries under TEA. Patients were allocated into two groups of 30 each. Group A received 15 ml of 0.5% levobupivacaine, while Group B received 15 ml of 0.75% ropivacaine. Onset of sensory block, time to maximum sensory level, duration of epidural anaesthesia, intraoperative fentanyl requirement, haemodynamic parameters, conversion to general anaesthesia, adverse effects, and postoperative VAS scores were recorded.
Results
Levobupivacaine produced significantly faster onset of sensory block, shorter time to maximum sensory level, longer duration of epidural anaesthesia, lower fentanyl requirement, and lower VAS scores at 1 and 2 hours compared with ropivacaine. Haemodynamic stability and adverse effects were comparable.
Conclusion
Levobupivacaine 0.5% provided superior sensory blockade and early postoperative analgesia compared with ropivacaine 0.75%, with comparable safety.
Zitieren
APA
Thrilochan, C. A., G, B., Sundeep, M., Prabhu, J. R., & Lavudi, U. (2026). A Study Comparing 0.5% Levobupivacaine and 0.75% Ropivacaine for Thoracic Epidural Anaesthesia in Abdominal Surgeries. International Journal of Pharmaceutical Quality Assurance, 17(06). https://doi.org/10.25258/ijpqa.17.6.17
Vancouver
Thrilochan CA, G B, Sundeep M, Prabhu JR, Lavudi U. A Study Comparing 0.5% Levobupivacaine and 0.75% Ropivacaine for Thoracic Epidural Anaesthesia in Abdominal Surgeries. International Journal of Pharmaceutical Quality Assurance. 2026;17(06). doi:10.25258/ijpqa.17.6.17
BibTeX
@article{Thrilochan2026,
author = {Thrilochan, Chandaka Aditya and G, Balakrishna and Sundeep, Medabalimi and Prabhu, J. Rameshwari and Lavudi, Umamaheswari},
title = {A Study Comparing 0.5% Levobupivacaine and 0.75% Ropivacaine for Thoracic Epidural Anaesthesia in Abdominal Surgeries},
journal = {International Journal of Pharmaceutical Quality Assurance},
year = {2026},
volume = {17},
number = {06},
doi = {10.25258/ijpqa.17.6.17}
}
EUVIMED